Have a personal or library account? Click to login
Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials Cover

Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials

Current Issues in Pharmacy and Medical Sciences
Volume 34 (2021): Issue 3 (September 2021)
By: Syed Wasif Gillani,  Anam Azhar,  Shabaz Mohiuddin Gulam,  Fithawit Bahran Gebreigziabher and  Hassaan Anwer Rathore  
Open Access
|Oct 2021
DOI: https://doi.org/10.2478/cipms-2021-0024 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 123 - 129
Submitted on: Jan 6, 2021
|
Accepted on: Jun 12, 2021
|
Published on: Oct 8, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
meta-analysis,
type 1 diabetes,
empagliflozin,
placebo,
evidence-based practice
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2021 Syed Wasif Gillani, Anam Azhar, Shabaz Mohiuddin Gulam, Fithawit Bahran Gebreigziabher, Hassaan Anwer Rathore, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 34 (2021): Issue 3 (September 2021)Next article